PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 671.00
Bid: 671.00
Ask: 672.00
Change: 1.00 (0.15%)
Spread: 1.00 (0.149%)
Open: 673.00
High: 674.50
Low: 668.00
Prev. Close: 670.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board changes

29 Oct 2014 10:00

29 October 2014

Tate & Lyle PLC

Board changes

Tate & Lyle PLC (the “Company”) announces that Paul Forman has been appointed as a Non-Executive Director and a member of the Audit, Remuneration and Nominations Committees with effect from 1 January 2015.

Paul is Group Chief Executive of Coats plc, a leading industrial thread and consumer textile crafts business. Prior to joining Coats in 2009, he was Group Chief Executive of Low & Bonar PLC, a global performance materials group, and was previously Managing Director at Unipart International, a leading European automotive aftermarket supplier. Paul also served as a non-executive director at Brammer PLC from 2006 to 2010.

The Company further announces that Liz Airey, currently Chairman of the Audit Committee, will become Senior Independent Director and Anne Minto will assume the chairmanship of the Remuneration Committee with effect from 1 January 2015, after Robert Walker steps down from the Board following the completion of his term of appointment on 31 December 2014. Douglas Hurt will succeed Liz Airey as Chairman of the Audit Committee with effect from 1 March 2015 and will also replace her as a member of the Corporate Responsibility Committee from that date.

Sir Peter Gershon, Chairman of Tate & Lyle, said "I am delighted that Paul has agreed to join the Board. His wide experience of managing international businesses, developing business-to-business customer and market-led strategies, and commercialising innovation pipelines will be of significant benefit to the Board.

“I would also like to thank Robert for his nine years of exemplary service and significant contribution to the Board and the Remuneration Committee at a critical period in the Group’s transformation.”

There are no further disclosures to be made in connection with Mr Forman’s appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority’s Listing Rules.

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 20 7269 7113 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development group. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2014, Tate & Lyle sales totalled £3.1 billion. http://www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC.

Copyright Business Wire 2014

Date   Source Headline
17th Dec 20145:39 pmBUSTransaction in Own Shares
5th Dec 20145:26 pmBUSTransaction in Own Shares
5th Dec 20145:25 pmBUSHolding(s) in Company
5th Dec 201410:14 amBUSDirector/PDMR Shareholding
5th Dec 201410:05 amBUSDirector/PDMR Shareholding
4th Dec 20145:16 pmBUSTransaction in Own Shares
3rd Dec 20145:41 pmBUSTransaction in Own Shares
2nd Dec 20145:19 pmBUSTransaction in Own Shares
1st Dec 20145:51 pmBUSTransaction in Own Shares
1st Dec 201411:10 amBUSTotal Voting Rights
18th Nov 20142:34 pmBUSDirector/PDMR Shareholding
11th Nov 201410:42 amBUSDirector/PDMR Shareholding
6th Nov 20145:07 pmBUSDirector/PDMR Shareholding
6th Nov 20147:00 amBUSHalf-yearly Report
29th Oct 201410:00 amBUSBoard changes
16th Oct 20145:55 pmBUSHolding(s) in Company
1st Oct 20145:19 pmBUSHolding(s) in Company
1st Oct 20141:29 pmBUSTotal Voting Rights
29th Sep 20145:39 pmBUSDirector/PDMR Shareholding
26th Sep 20141:47 pmBUSDirector/PDMR Shareholding
23rd Sep 20147:00 amBUSTrading Statement
22nd Sep 20146:24 pmBUSHolding(s) in Company
19th Sep 201412:48 pmBUSHolding(s) in Company
1st Sep 20149:37 amBUSTotal Voting Rights
4th Aug 20144:53 pmBUSDirector/PDMR Shareholding
1st Aug 20144:38 pmBUSHolding(s) in Company
1st Aug 201412:05 pmBUSHolding(s) in Company
1st Aug 201410:00 amBUSTotal Voting Rights
31st Jul 20145:26 pmBUSDirector/PDMR Shareholding
31st Jul 201410:42 amBUSDirector/PDMR Shareholding
24th Jul 20143:38 pmBUSResult of AGM
24th Jul 20147:00 amBUSInterim Management Statement
8th Jul 201410:01 amBUSDirector/PDMR Shareholding
2nd Jul 20146:02 pmBUSDirector/PDMR Shareholding
1st Jul 20149:54 amBUSBlocklisting Interim Review
1st Jul 20149:45 amBUSTotal Voting Rights
25th Jun 20142:55 pmBUSDirector Declaration
24th Jun 20146:05 pmBUSDirector/PDMR Shareholding
24th Jun 20147:00 amBUSDirectorate Change
23rd Jun 20144:47 pmBUSAnnual Financial Report
20th Jun 201410:14 amBUSDirector/PDMR Shareholding
6th Jun 20144:59 pmBUSDirector/PDMR Shareholding
4th Jun 20145:33 pmBUSDirector/PDMR Shareholding
2nd Jun 20149:09 amBUSTotal Voting Rights
29th May 20145:15 pmBUSDirector/PDMR Shareholding
29th May 20147:01 amBUSEffect of Adoption of IFRS 11 ‘Joint Arrangements’
29th May 20147:00 amBUSFinal Results
1st May 201410:18 amBUSTotal Voting Rights
3rd Apr 20147:00 amBUSTrading Statement
2nd Apr 20144:45 pmBUSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.